Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use

被引:16
作者
Matsushima, T. [1 ]
Akira, S. [2 ]
Asakura, H. [1 ]
Takeshita, T. [2 ]
机构
[1] Musashikosugi Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan
[2] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo, Japan
关键词
Adenomyosis; Cerebral venous and sinus thrombosis; Low-dose gonadotropin-releasing hormone agonist therapy; Low-dose oral contraceptive;
D O I
10.12891/ceog3214.2017
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
The authors report a case of cerebral venous and sinus thrombosis (CVST) in a patient receiving a low-dose estrogen-progestin combination (oral contraceptives, OCs) for uterine adenomyosis. She was switched to gonadotropin-releasing hormone agonist (GnRHa) draw-back therapy, which was successfully administered long-term. Case: The patient was a 38-year-old nulligravida with a history of smoking. She presented to this hospital with dysmenorrhea and postmenstrual lower abdominal pain. Adenomyosis was diagnosed using ultrasound and magnetic resonance imaging. She was instructed to stop smoking and was administered low-dose OCs. CVST occurred 18 months later. OC therapy was halted, and only antiplatelet therapy was administered. After six months, her chief complaint symptoms intensified, therefore GnRHa draw-back therapy was administered after obtaining informed consent. No uterine enlargement was observed, and the abdominal pain resolved. During 2.5 years of therapy, her bone density levels remained within normal limits. CVST did not recur and no other thromboses were observed.
引用
收藏
页码:143 / 145
页数:3
相关论文
共 15 条
[1]
Akira S, 2009, CLIN EXP OBSTET GYN, V36, P123
[2]
Akira S, 2009, MED SCI MONITOR, V15, pCR1
[3]
Cerebral sinus venous thrombosis [J].
Alvis-Miranda, Hernando Raphael ;
Castellar-Leones, Sandra Milena ;
Alcala-Cerra, Gabriel ;
Moscote-Salazar, Luis Rafael .
JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2013, 4 (04) :427-438
[4]
Cerebral venous thrombosis, pregnancy and oral contraceptives [J].
Bousser, Marie-Germaine ;
Crassard, Isabelle .
THROMBOSIS RESEARCH, 2012, 130 :S19-S22
[5]
Medical and surgical management of adenomyosis [J].
Farquhar, Cynthia ;
Brosens, Ivo .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2006, 20 (04) :603-616
[6]
Prognosis of cerebral vein and dural sinus thrombosis - Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) [J].
Ferro, JM ;
Canhao, P ;
Stam, J ;
Bousser, MG ;
Barinagarrementeria, F .
STROKE, 2004, 35 (03) :664-670
[7]
Cerebral Venous Sinus Thrombosis: Update on Diagnosis and Management [J].
Ferro, Jose M. ;
Canhao, Patricia .
CURRENT CARDIOLOGY REPORTS, 2014, 16 (09)
[8]
Oral contraceptives and venous thromboembolism: A systematic review and meta-analysis [J].
Lamberto Manzoli ;
Corrado De Vito ;
Carolina Marzuillo ;
Antonio Boccia ;
Paolo Villari .
Drug Safety, 2012, 35 (3) :191-205
[9]
McLaren James Samuel, 2012, Menopause Int, V18, P68, DOI 10.1258/mi.2012.012008
[10]
Cerebral Dural Sinus Thrombosis Associated with Adenomyosis: A Case Report [J].
Nishioka, Kenya ;
Tanaka, Ryota ;
Tsutsumi, Satoshi ;
Yamashiro, Kazuo ;
Nakahara, Mariko ;
Shimura, Hideki ;
Hattori, Nobutaka ;
Urabe, Takao .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (07) :1985-1987